These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28329322)

  • 1. Utilization and in-hospital complications of cardiac resynchronization therapy: trends in the United States from 2003 to 2013.
    Hosseini SM; Moazzami K; Rozen G; Vaid J; Saleh A; Heist KE; Vangel M; Ruskin JN
    Eur Heart J; 2017 Jul; 38(27):2122-2128. PubMed ID: 28329322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of in-hospital adverse outcomes and cost utilization associated with cardiac resynchronization therapy defibrillator implantation in the United States.
    Patel N; Viles-Gonzalez J; Agnihotri K; Arora S; Patel NJ; Aneja E; Shah M; Badheka AO; Pothineni NV; Kancharla K; Mulpuru S; Noseworthy PA; Kusumoto F; Cha YM; Deshmukh AJ
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1425-1435. PubMed ID: 30016005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Trends in the Use of Cardiac Resynchronization Therapy With or Without Implantable Cardioverter-Defibrillator.
    Lindvall C; Chatterjee NA; Chang Y; Chernack B; Jackson VA; Singh JP; Metlay JP
    Circulation; 2016 Jan; 133(3):273-81. PubMed ID: 26635400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex Disparities in the Choice of Cardiac Resynchronization Therapy Device: An Analysis of Trends, Predictors, and Outcomes.
    Mohamed MO; Contractor T; Zachariah D; van Spall HGC; Parwani P; Minissian MB; Rashid M; Martin GP; Barker D; Patwala A; Mamas MA
    Can J Cardiol; 2021 Jan; 37(1):86-93. PubMed ID: 32376344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac device implantation in the United States from 1997 through 2004: a population-based analysis.
    Zhan C; Baine WB; Sedrakyan A; Steiner C
    J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):13-9. PubMed ID: 18095038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes.
    Sridhar AR; Yarlagadda V; Parasa S; Reddy YM; Patel D; Lakkireddy D; Wilkoff BL; Dawn B
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003108. PubMed ID: 26921376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of haematoma after pacemaker and CRT device implantation on hospitalization costs, length of stay, and mortality: a population-based study.
    Sridhar AR; Yarlagadda V; Yeruva MR; Kanmanthareddy A; Vallakati A; Dawn B; Lakkireddy D
    Europace; 2015 Oct; 17(10):1548-54. PubMed ID: 25855676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcomes of cardiac tamponade in patients undergoing cardiac resynchronization therapy.
    Adegbala O; Olagoke O; Adejumo A; Akintoye E; Oluwole A; Alebna P; Williams K; Lieberman R; Afonso L
    Int J Cardiol; 2018 Dec; 272():137-141. PubMed ID: 30045818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence, mortality and predictors of complicated cardiac perforation in patients with CRT-D: Based on the National Inpatient Sample registry.
    Kawata H; Erande A; Lafi O; Chen CW; Hirai T; Santucci P; Malik S
    Int J Cardiol; 2019 Oct; 293():109-114. PubMed ID: 31147194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
    Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W
    Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing sex differences in the use of cardiac resynchronization therapy with or without implantable cardioverter-defibrillator.
    Chatterjee NA; Borgquist R; Chang Y; Lewey J; Jackson VA; Singh JP; Metlay JP; Lindvall C
    Eur Heart J; 2017 May; 38(19):1485-1494. PubMed ID: 28065904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends and outcomes of cardiac resynchronization therapy upgrade procedures: A comparative analysis using a United States National Database 2003-2013.
    Cheung JW; Ip JE; Markowitz SM; Liu CF; Thomas G; Feldman DN; Swaminathan RV; Lerman BB; Kim LK
    Heart Rhythm; 2017 Jul; 14(7):1043-1050. PubMed ID: 28214565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF;
    Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator.
    Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?
    Heidenreich PA; Tsai V; Bao H; Curtis J; Goldstein M; Curtis L; Hernandez A; Peterson P; Turakhia MP; Masoudi FA
    JACC Heart Fail; 2015 Jun; 3(6):497-504. PubMed ID: 25982109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of institutional procedural volume on inhospital outcomes after cardiac resynchronization therapy device implantation: US national database 2003-2011.
    Yeo I; Kim LK; Lerman BB; Cheung JW
    Heart Rhythm; 2017 Dec; 14(12):1826-1832. PubMed ID: 28917564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.